MissionEnabling better & safer vaccines and (bio)pharmaceuticals by providing technology and know-how to shape, control and direct protein structure towards wanted function.
Strategy
Using our insight in the crossbeta pathway and its function in the removal of “obsolete” proteins, Crossbeta Biosciences has opened the door to a plethora of applications in the fields of adjuvant technology, protein therapeutics and diseases involving crossbeta structures. Crossbeta Biosciences intends to develop certain applications itself and certain applications in co-development. Other applications will be spun out or licensed out. Crossbeta Biosciences has and always will make sure, that all envisaged applications are brought to a level where they can procure intellectual property rights.. Crossbeta Biosciences will use funds obtained from partnerships and licenses to further develop and accelerate the development of its “own” applications.
At the present time Crossbeta Biosciences is actively pursuing partnerships with global pharmaceutical players in the field of its adjuvant technology.
|
Home